Wockhardt slips nearly 4 per cent as Illinois unit comes under USFDA scanner

NEW DELHI: Wockhardt Ltd slipped as much as 3.7 per cent in trade on Wednesday after media reports said that the US regulator has identified deficiencies in quality, hygiene and personnel training standards at Wockhardt's Morton Grove manufacturing unit at Illinois in the US.

The concerns raised by the USFDA are similar to those found at its facilities in India in the past.

Wockhardt ended the day 4.15 per cent lower at Rs 571.75. It hit a low of Rs 566 and a high of Rs 587 in trade today.

The Mount Grove unit is a key facility for Wockhardt as it is its sole manufacturing site in the US and production from here accounts for around half of the drugmaker's US revenues. Wockhardt's sales in the US market contributed 45 per cent to its overall turnover in 2013-14, or R2,173.5 crore, said media reports.